Your browser doesn't support javascript.
loading
Pharmacokinetics and Safety of a Novel Oral Liquid Formulation of 13-cis Retinoic Acid in Children with Neuroblastoma: A Randomized Crossover Clinical Trial.
Veal, Gareth J; Tweddle, Deborah A; Visser, Johannes; Errington, Julie; Buck, Helen; Marange, Josephine; Moss, Jon; Joseph, Shiju; Mulla, Hussain.
Afiliação
  • Veal GJ; Newcastle University Centre for Cancer, Translational & Clinical Research Institute Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
  • Tweddle DA; Newcastle University Centre for Cancer, Translational & Clinical Research Institute Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
  • Visser J; Great North Children's Hospital, Newcastle upon Tyne NE1 4LP, UK.
  • Errington J; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
  • Buck H; Newcastle University Centre for Cancer, Translational & Clinical Research Institute Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
  • Marange J; ClinPsy Limited, St. Albans, Hertfordshire AL3 5HN, UK.
  • Moss J; Nova Laboratories Limited, Leicester LE18 4YL, UK.
  • Joseph S; BAST Inc Limited, Loughborough Innovation Centre, Loughborough LE11 3AQ, UK.
  • Mulla H; BAST Inc Limited, Loughborough Innovation Centre, Loughborough LE11 3AQ, UK.
Cancers (Basel) ; 13(8)2021 Apr 14.
Article em En | MEDLINE | ID: mdl-33919763

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido